| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Revenue | $19.2M | +117.2% |
| R&D Expense | $69.7M | +18.1% |
| SG&A Expense | $30.5M | +42.7% |
| Operating Income | -$81.1M | -13.2% |
| Net Income | -$80.8M | -14.2% |
| EPS (Basic) | -$2.29 | +17.9% |
| EPS (Diluted) | -$2.29 | +17.9% |
| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $35.4M | -37.9% |
| Current Assets | $226.0M | +89.1% |
| Total Assets | $235.0M | +81.4% |
| Current Liabilities | $19.2M | -28.2% |
| Total Liabilities | $23.5M | -31.8% |
| Stockholders' Equity | $211.5M | +122.2% |
| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$78.5M | -46.3% |
| Capital Expenditures | $1.7M | +27.6% |
| Investing Cash Flow | -$129.7M | -126.9% |
| Financing Cash Flow | $186.5M | +162.2% |
| Free Cash Flow | -$80.2M | -45.8% |